| 2024-06-03 | Sale | Vaxcyte, Inc. PCVX | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $72.06 | $120,127 | +0.72% | |
| 2024-05-01 | Sale | Vaxcyte, Inc. PCVX | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $61.74 | $102,921 | +12.55% | |
| 2024-04-01 | Sale | Vaxcyte, Inc. PCVX | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $66.73 | $111,234 | +1.05% | |
| 2024-03-01 | Sale | Vaxcyte, Inc. PCVX | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0016% | $73.73 | $122,907 | -4.74% | |
| 2024-02-01 | Sale | Vaxcyte, Inc. PCVX | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0019% | $73.87 | $123,144 | -6.86% | |
| 2024-01-02 | Sale | Vaxcyte, Inc. PCVX | SVP, Gen Counsel & Corp Sec | 1,667 0.0018% | $63.93 | $106,579 | +9.39% | |
| 2023-12-07 | Sale | Vaxcyte, Inc. PCVX | SVP, Gen Counsel & Corp Sec | 10,000 0.0104% | $56.50 | $565,000 | +18.64% | |
| 2023-10-02 | Sale | Vaxcyte, Inc. PCVX | SVP, Gen Counsel & Corp Sec | 20,000 0.0219% | $50.40 | $1.01M | +29.2% |